AIP
ALBO

Ameritas Investment Partners’s Albireo Pharma Inc ALBO Stock Holding History

Ameritas Investment Partners’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,419
Closed -$62.2K – 3036
2022
Q4 		$62.2K Hold
1,419
– – ﹤0.01% 1912
2022
Q3 		$27K Hold
1,419
– – ﹤0.01% 2374
2022
Q2 		$28K Hold
1,419
– – ﹤0.01% 2374
2022
Q1 		$42K Hold
1,419
– – ﹤0.01% 2163
2021
Q4 		$33K Hold
1,419
– – ﹤0.01% 2395
2021
Q3 		$44K Hold
1,419
– – ﹤0.01% 2252
2021
Q2 		$50K Hold
1,419
– – ﹤0.01% 2192
2021
Q1 		$50K Hold
1,419
– – ﹤0.01% 2089
2020
Q4 		$53K Buy
1,419
+445
+46% +$16.2K ﹤0.01% 1965
2020
Q3 		$33K Hold
974
– – ﹤0.01% 2103
2020
Q2 		$26K Hold
974
– – ﹤0.01% 2222
2020
Q1 		$16K Buy
974
+286
+42% +$6.29K ﹤0.01% 2314
2019
Q4 		$17K Hold
688
– – ﹤0.01% 2498
2019
Q3 		$14K Hold
688
– – ﹤0.01% 2591
2019
Q2 		$22K Hold
688
– – ﹤0.01% 2402
2019
Q1 		$22K Hold
688
– – ﹤0.01% 2340
2018
Q4 		$17K Hold
688
– – ﹤0.01% 2445
2018
Q3 		$23K Hold
688
– – ﹤0.01% 2450
2018
Q2 		$24K Buy
+688
New +$22.3K ﹤0.01% 2416

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ameritas Investment Partners's ALBO Position: Q1 2023 in Review

Ameritas Investment Partners sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 1,419 shares — an estimated $62.2K sold.

Ameritas Investment Partners first reported a position in ALBO in Q2 2018 and held it in 19 quarters. The position peaked at $62.2K in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Ameritas Investment Partners reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,419 Albireo Pharma Inc shares in Q1 2023, an estimated $62.2K.
  • Ameritas Investment Partners first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 19 quarters.
  • Ameritas Investment Partners's Albireo Pharma Inc position peaked at $62.2K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Ameritas Investment Partners's 13F filing for Q1 2023, filed 10 May 2023.